Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

LFTBearishLegalnews

High materiality7/10

LFT faces NYSE price deficiency; six-month window to regain compliance

Jul 30, 2026, 4:36 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Regulatory deficiency raises liquidity risk and near-term sentiment headwinds; potential sudden actions like reverse split could dilute equity and pressure share price until a cure is achieved.

AI summary

What happened, with direct paths to the underlying reporting

LFT disclosed NYSE deficiency after its 30-day average closing price fell below $1, triggering a cure period through January 24, 2027. The company can regain compliance via price recovery or a corporate action like a reverse stock split, but no action is guaranteed, which may heighten near-term volatility and liquidity concerns.

NYSE issues deficiency notice after LFT's 30-day average price fell below $1.
Not delisted; six-month cure period to regain compliance by Jan 24, 2027.
Possible remedies include a reverse stock split; no action commitments yet.
LFT concentrates on floating-rate CRE debt; managed by Lument.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.